Overview
Mary Aronow is an Ophthalmologist in Mount Airy, Maryland. Dr. Aronow is rated as an Advanced provider by MediFind in the treatment of Late-Onset Retinal Degeneration. Her top areas of expertise are Melanoma of the Eye, Choroid Plexus Carcinoma, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy. Dr. Aronow is currently accepting new patients.
Her clinical research consists of co-authoring 47 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Late-Onset Retinal Degeneration.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Emily Chew is an Ophthalmologist in Bethesda, Maryland. Dr. Chew is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Retinopathy, and Cataract Removal.
The Johns Hopkins Hospital
Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.
Catherine Cukras is an Ophthalmologist in Bethesda, Maryland. Dr. Cukras is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. Her top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Retinopathy Pigmentary Mental Retardation.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Melanoma of the EyeDr. Aronow isElite. Learn about Melanoma of the Eye.
- Distinguished
- Choroid Plexus CarcinomaDr. Aronow isDistinguished. Learn about Choroid Plexus Carcinoma.
- Metastatic Uveal MelanomaDr. Aronow isDistinguished. Learn about Metastatic Uveal Melanoma.
- Retinal Vein OcclusionDr. Aronow isDistinguished. Learn about Retinal Vein Occlusion.
- Uveal MelanomaDr. Aronow isDistinguished. Learn about Uveal Melanoma.
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Diabetic RetinopathyDr. Aronow isAdvanced. Learn about Diabetic Retinopathy.
- Late-Onset Retinal DegenerationDr. Aronow isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Retinal Artery OcclusionDr. Aronow isAdvanced. Learn about Retinal Artery Occlusion.
- RetinoblastomaDr. Aronow isAdvanced. Learn about Retinoblastoma.
- VitrectomyDr. Aronow isAdvanced. Learn about Vitrectomy.
- Experienced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Central Serous ChorioretinopathyDr. Aronow isExperienced. Learn about Central Serous Chorioretinopathy.
- Cone DystrophyDr. Aronow isExperienced. Learn about Cone Dystrophy.
- Cone Rod Dystrophy Amelogenesis Imperfecta
- Cone-Rod DystrophyDr. Aronow isExperienced. Learn about Cone-Rod Dystrophy.
- Doyne Honeycomb Retinal DystrophyDr. Aronow isExperienced. Learn about Doyne Honeycomb Retinal Dystrophy.
